Scotia Capital’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-14,949
| Closed | -$655K | – | 902 |
|
|
2021
Q4 | $655K | Buy |
14,949
+100
| +0.7% | +$4.38K | ﹤0.01% | 581 |
|
|
2021
Q3 | $753K | Sell |
14,849
-367
| -2% | -$18.6K | 0.01% | 550 |
|
|
2021
Q2 | $792K | Sell |
15,216
-3,885
| -20% | -$202K | 0.01% | 550 |
|
|
2021
Q1 | $873K | Buy |
19,101
+490
| +3% | +$22.4K | 0.01% | 511 |
|
|
2020
Q4 | $855K | Buy |
18,611
+644
| +4% | +$29.6K | 0.01% | 463 |
|
|
2020
Q3 | $700K | Buy |
+17,967
| New | +$700K | 0.01% | 441 |
|